MedTrace Logo

tDCS Versus tsDCS for Endometriosis-related Chronic Pelvic Pain Treatment

NCT02958423 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-11-08

No results posted yet for this study

Summary

The purpose of the study is to compare the analgesic effect of 2 mA anodal direct current stimulation on the right primary motor cortex (M1) (tDCS) with a similar stimulation on the spine (D10) (tsDCS) in healthy volunteers (HV) followed by a pilot study in patients suffering of endometriosis-related chronic pelvic pain (CPP)

Conditions

  • Endometriosis
  • Pelvic Pain
  • Transcranial Direct Current Stimulation
  • Spinal Cord Stimulation

Interventions

DEVICE

Transcranial DCS Healthy Volunteers

The DC stimulator manufactured by NeuroConn (Germany) will be used to deliver anodal direct current stimulation over the right primary motor cortex of healthy volunteers

DEVICE

Transspinal DCS Healthy Volunteers

The DC stimulator manufactured by NeuroConn (Germany) will be used to deliver anodal direct current stimulation over the D10 spinal process of healthy volunteers

DEVICE

Transcranial DCS CPP patients

The DC stimulator manufactured by NeuroConn (Germany) will be used to deliver anodal direct current stimulation over the right primary motor cortex of CPP patients

DEVICE

Transspinal DCS CPP patients

The DC stimulator manufactured by NeuroConn (Germany) will be used to deliver anodal direct current stimulation over the D10 spinal process of CPP patients

Sponsors & Collaborators

  • Jean Schoenen

    lead OTHER

Principal Investigators

  • Michelle Nisolle, Professor · University of Liege

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-11-30
Completion
2018-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02958423 on ClinicalTrials.gov